Foot infections in diabetes (DFIs) in the out-patient setting: An Italian multicentre observational survey

Diabetic Medicine

Volumn 25, Issue 8, 2008, Pages 979-984

  Esposito, S ^a,d   Leone, S ^a   Noviello, S ^a   Fiore, M ^a   Ianniello, F ^a   Felaco, F M ^a   Romagnoli, F ^b   Sarli, E ^c  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b INRCA   (Italy)

^c Italian Association MetaDiaInf   (Italy)

^d Clinica Malattie Infettive   (Italy)

Author keywords

Diabetic foot infections; Out patient setting; Piperacillin tazobactam; Pseudomonas spp.

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIDIABETIC AGENT; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; INSULIN; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TEICOPLANIN;

ADULT; AGED; ANAEROBE; ANAEROBIC BACTERIUM; ARTICLE; BACTERIUM CULTURE; CLINICAL TRIAL; CONTROLLED STUDY; DEBRIDEMENT; DIABETES MELLITUS; DIABETIC FOOT; DISEASE SEVERITY; ENTEROBACTERIACEAE; ENTEROCOCCACEAE; FEMALE; FOOT AMPUTATION; FOOT ULCER; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OSTEOMYELITIS; OUTPATIENT; PATHOGENESIS; PSEUDOMONAS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCACEAE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DIABETIC FOOT; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; PENICILLANIC ACID; PIPERACILLIN; PSEUDOMONAS INFECTIONS; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 48149097056     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2008.02507.x     Document Type: Article

References (37)

1. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005 293 : 217 228.
2. Katsilambros N, Dounis E, Tsapogas P, et al. Atlas of the Diabetic Foot. Hoboken, NJ : John Wiley & Sons, Ltd, 2003.
3. Lipsky BA, Itani K, Norden C Linezolid Diabetic Foot Infections Study Group. Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin- clavulanate. Clin Infect Dis 2004 38 : 17 24.
4. Lipsky BA, Stoutenburgh U. Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections. J Antimicrob Chemother 2005 55 : 240 245.
5. Lipsky BA, Armstrong DG, Citron DM, Tice AD, Morgenstern DE, Abramson MA. Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial. Lancet 2005 366 : 1695 1703.
6. Lipsky BA, Giordano P, Choudhri S, Song J. Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate. J Antimicrob Chemother 2007 60 : 370 376.
7. Lipsky BA, Baker PD, Landon GC, Fernau R. Antibiotic therapy for diabetic foot infections: comparison of two parenteral-to-oral regimens. Clin Infect Dis 1997 24 : 643 648.
8. Marvaso A, Esposito S, Noviello S, Ianniello F, Leone S, Miaello A. Outpatient Parenteral Antibiotic Therapy (OPAT) of diabetic foot infections with piperacillin/tazobactam. Infez Med 2002 10 : 230 235.
9. Sumpio BE. Foot ulcers. N Engl J Med 2000 343 : 787 793.
10. Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004 39 : 885 910.
11. Crane M, Werber B. Critical pathway approach to diabetic pedal infections in a multidisciplinary setting. J Foot Ankle Surg 1999 38 : 30 33.
12. Edelson GW, Armstrong DG, Lavery LA, Caicco G. The acutely infected diabetic foot is not adequately evaluated in an inpatient setting. Arch Intern Med 1996 156 : 2373 2378.
13. Lipsky BA. A report from the international consensus on diagnosing and treating the infected diabetic foot. Diabetes Metab Res Rev 2004 20 : S68 S77.
14. World Health Organization Expert Committee. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation, part I: Diagnosis and Classification of Diabetes Mellitus. Geneva : World Health Organization, 1999.
15. Armstrong DG, Lavery LA, Harkless LB. Classification of diabetic foot wounds. J Foot Ankle Surg 1996 35 : 528 531.
16. Kaufman J, Breeding L, Rosenberg N. Anatomic location of acute diabetic foot infection. Its influence on the outcome of treatment. Am Surg 1987 53 : 109 112.
17. Lipsky BA. Osteomyelitis of the foot in diabetic patients. Clin Infect Dis 1997 25 : 1318 1326.
18. Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA. Risk factors for foot infections in individuals with diabetes. Diabetes Care 2006 29 : 1288 1293.
19. Lipsky BA, Pecoraro RE, Larson SA, Hanley ME, Ahroni JH. Outpatient management of uncomplicated lower-extremity infections in diabetic patients. Arch Intern Med 1990 150 : 790 797.
20. Lipsky BA, Sheehan P, Armstrong DG, Tice AD, Polis AB, Abramson MA. Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial. Int Wound J 2007 4 : 30 38.
21. Wheat J. Diagnostic strategies in osteomyelitis. Am J Med 1985 78 : 218 224.
22. Sapico FL, Witte JL, Canawati HN, Montgomerie JZ, Bessman AN. The infected foot of the diabetic patient: quantitative microbiology and analysis of clinical features. Rev Infect Dis 1984 6 (Suppl. 1 171 176.
23. Ge Y, MacDonald D, Hait H, Lipsky B, Zasloff M, Holroyd K. Microbiological profile of infected diabetic foot ulcers. Diabet Med 2002 19 : 1032 1035.
24. Fierer J, Daniel D, Davis C. The fetid foot: lower-extremity infections in patients with diabetes mellitus. Rev Infect Dis 1979 1 : 210 217.
25. Sims D, Keating SE, DeVincentis AF. Bacteriology of diabetic foot ulcers. J Foot Surg 1984 23 : 149 151.
26. Urbancic-Rovan V, Gubina M. Infection in superficial diabetic foot ulcers. Clin Infect Dis 1997 25 : 184 185.
27. Wheat LJ, Allen SD, Henry M, Kernek CB, Siders JA, Kuebler T. Diabetic foot infections. Arch Intern Med 1986 146 : 1935 1940.
28. Abdulrazak A, Bitar ZI, Al-Shamali AA, Mobasher LA. Bacteriological study of diabetic foot infections. J Diabetes Complications 2005 19 : 138 141.
29. Edmond M, Foster A. The use of antibiotics in the diabetic foot. Am J Surg 2004 187 : 25 28.
30. Shankar EM, Mohan V, Premalatha G, Srinivasan RS, Usha AR. Bacterial etiology of diabetic foot infections in South India. Eur J Intern Med 2005 16 : 567 570.
31. Perry CM, Markham A. Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections. Drugs 1999 57 : 805 843.
32. Verbist L, Verhaegen J, Wouters C, Vandenhoven G. Comparative activity of piperacillin/tazobactam against 5625 isolates from hospitalised patients. Multicentre Study Group. J Antimicrob Chemother 1996 37 : 285 293.
33. Doern GV, Jones RN, Pfaller MA, Erwin M, Ramirez-Rhonda C. Multicenter evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents in Puerto Rico. The Puerto Rico Antimicrobial Resistance Study Group. Diagn Microbiol Infect Dis 1998 30 : 113 119.
34. Dembry LM, Roberts JC, Schock KD, Marino SP, Farrell PA, Andriole VT. Comparison of in vitro activity of trovafloxacin against gram-positive and gram-negative organisms with quinolones and beta-lactam antimicrobial agents. Diagn Microbiol Infect Dis 1998 31 : 301 311.
35. Zeillemaker AM, Veldkamp KE, van Kraaij MG, Hoekstra JB, Hoynck van Papendrecht AA, Diepersloot RJ. Piperacillin/tazobactam therapy for diabetic foot infection. Foot Ankle Int 1998 19 : 169 172.
36. Siami FS, LaFleur BJ, Siami GA. Clinafloxacin versus piperacillin/ tazobactam in the treatment of severe skin and soft-tissue infections in adults at a Veterans Affairs medical center. Clin Ther 2002 24 : 59 72.
37. Harkless L, Boghossian J, Pollak R, Caputo W, Dana A, Gray S. An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers. Surg Infect 2005 6 : 27 40.